Attached files

file filename
10-Q - 10-Q - Advanced Life Sciences Holdings, Inc.a10-12772_110q.htm
EX-31.1 - EX-31.1 - Advanced Life Sciences Holdings, Inc.a10-12772_1ex31d1.htm
EX-31.2 - EX-31.2 - Advanced Life Sciences Holdings, Inc.a10-12772_1ex31d2.htm
EX-32.2 - EX-32.2 - Advanced Life Sciences Holdings, Inc.a10-12772_1ex32d2.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350

 

In connection with the quarterly report on Form 10-Q of Advanced Life Sciences Holdings, Inc. (the “Company”) for the fiscal quarter ending June 30, 2010 (the “Report”), I, Michael T. Flavin, Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 to the extent applicable; and

 

(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: August 11, 2010

 

 

 

 

 

/s/ Michael T. Flavin

 

Michael T. Flavin

 

Chief Executive Officer

 

Advanced Life Sciences Holdings, Inc.